Download App

Log in to access Online Inquiry
Company Overview More
Sinopharm holding Co., Ltd. is a Chinese company mainly engaged in the distribution of drugs and medical devices. The company operates through four departments. The pharmaceutical distribution department distributes pharmaceutical products to customers such as hospitals, other distributors, retail pharmacies and clinics. The medical device business unit distributes medical devices to customers and provides installation and maintenance services. The pharmaceutical retail business department operates pharmaceutical chain stores. Other business units distribute laboratory supplies, manufacture and distribute chemical reagents, and produce and sell pharmaceutical products.
CEO: Qingming Yu
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

01099 SINOPHARM
19.080+0.620+3.36%
YOY
Do not show
Hide blank lines
(Q3)2022/03/31(FY)2021/12/31(Q9)2021/09/30(Q6)2021/06/30
Assets
Current assets
Inventory
11.78% 56.3B 9.37% 51.5B 6.81% 52.07B 8.85% 50.82B
Accounts receivable
13.99% 193.22B 17.93% 171.39B 15.11% 192.23B 21.84% 190.19B
Notes receivable
12.77% 3.64B -- -- 6.4% 3.05B -- --
Insurance and other receivables-current assets
107.84% 13.5B -- -- 13.92% 6.34B -- --
Advance deposits and other receivables
-- -- -- -- -- -- -- 1.21M
Cash and equivalents
-5.9% 35.91B -13.25% 43.53B -16% 33.14B -12.62% 34.36B
Financial assets at fair value-current assets
-- -- -69.98% 11.75M -- -- -99.57% 169K
Other current assets
36.8% 1.07B -- -- 28.53% 830.28M -- --
Special items of current assets
-97.29% 181.65M -1.92% 24.49B -1.04% 6.98B 8.01% 24.58B
Adjustment items of current assets
-- -- -- -- -- 0.01 -- --
Total current assets
10.12% 314.61B 8.71% 290.92B 8.43% 304.34B 13.23% 299.95B
Non-current assets
Fixed assets
-0.17% 10.38B -- -- -0.24% 10.35B -- --
Property, plant and equipment
-- -- 2.95% 12.42B -- -- 3.26% 12.06B
Investment property
-4.7% 972.31M -7.21% 588.37M -5.77% 1B -7.69% 611.32M
Construction in progress
40.85% 807.7M -- -- 19.97% 688.64M -- --
Long-term receivables
-10.53% 2.4B -- -- -2.59% 2.59B -14.09% 28.49M
Development expenditure
1.14% 81.95M -- -- 7.81% 87.27M -- --
Associated company interest
-- -- 8.43% 8.39B -- -- 11.07% 8.02B
Interests in Joint Venture
-- -- -23.6% 27M -- -- -28.15% 25.74M
long-term investment
8.3% 8.61B -- -- 10.25% 8.26B -- --
Financial assets at fair value-non-current assets
-- -- 12.01% 688.56M -- -- -10.03% 613.97M
Intangible assets
-5.05% 4.53B -3.15% 10.39B -1.42% 4.74B 13.15% 11.01B
Goodwill
-6.07% 7.06B -- -- 3.71% 7.51B -- --
Deferred tax assets
12.76% 1.74B 11.58% 1.79B 9.06% 1.57B 14.44% 1.7B
Other illiquid assets
10.94% 2.72B -4.31% 3.12B 67.65% 2.72B 2.29% 3.36B
Special items of non-current assets
6.31% 6.56B 1.83% 7.08B 5.97% 6.49B 5.26% 6.96B
Total non-current assets
1.6% 45.95B 1.98% 44.49B 5.86% 46.08B 7.15% 44.38B
Total assets
8.96% 360.56B 7.77% 335.41B 8.09% 350.42B 12.4% 344.33B
Liabilities
Current liabilities
Accounts payable
18.44% 98.26B 14.03% 128.43B 9.28% 96.33B 24.08% 121.33B
Notes payable
8.36% 32.79B -- -- 16.01% 31.45B -- --
Tax payable
12.98% 1.9B 9.79% 1.61B -6.04% 2.09B 9.68% 1.17B
Dividend payable
-- -- 13.52% 246.21M -- -- 2.07% 2.34B
Other payables and accrued expenses
-0.67% 27.01B 1% 26.23B 8.14% 23.77B 18.27% 27.76B
Advance payment
656.86% 21.06M -- -- -- 22.29M -- --
Short-term borrowing
15.32% 62.09B -- -- 13.48% 63.28B -- --
Other loans-current liabilities
-- -- 0.35% 55.15B -- -- -5.18% 71.83B
Financial lease liabilities-current liabilities
-- -- 10.09% 1.55B -- -- 20.38% 1.36B
Other current liabilities
-46.04% 5.17B -- -- -61.24% 4.56B -- --
Special items of current liabilities
37.48% 8.79B -16.9% 6.09B 42.99% 6.53B -8.87% 6.54B
Total current liabilities
10.01% 242.15B 7.52% 219.31B 7.04% 235.15B 11.33% 232.32B
Net current assets
10.5% 72.47B 12.54% 71.62B 13.45% 69.19B 20.24% 67.64B
Total assets less current liabilities
6.86% 118.41B 8.25% 116.11B 10.29% 115.27B 14.69% 112.01B
Non-current liabilities
Long-term bank loan
14.35% 1.81B -- -- 119.69% 1.92B -- --
Other loans-non-current liabilities
-- -- -5.61% 8.42B -- -- 28.28% 10.32B
Long-term accounts payable
-36.46% 189.4M -- -- -33.41% 368.08M -- --
Long-term remuneration payable to staff and workers
-6.24% 87.23M -2.2% 387.7M 12.16% 94.79M -0.08% 393.56M
Financial lease liabilities-non-current liabilities
-- -- 0.21% 3.25B -- -- -0.73% 3.28B
Deferred tax liability
-4.67% 1.01B -8% 1.02B -5.64% 1.02B -0.17% 1.07B
Deferred income-non-current liabilities
-2.17% 394.87M -- -- 1.53% 398.9M -- --
Issued debt instrument
-23.01% 6.69B -- -- -13.09% 8.68B -- --
Other non-current liabilities
-11.06% 2.58B -7.65% 3.32B 71.61% 2.83B 78.81% 3.71B
Special items of non-current liabilities
-0.64% 3.39B 10.28% 56.75M -0.07% 3.58B -9.74% 62.24M
Total non-current liabilities
-12.41% 16.14B -4.97% 16.45B 3.77% 18.9B 25.9% 18.84B
Total liabilities
8.28% 258.29B 6.54% 235.76B 6.79% 254.05B 12.31% 251.15B
Total assets less total liabilities
10.71% 102.27B 10.79% 99.65B 11.67% 96.37B 12.66% 93.18B
Total equity and non-current liabilities
6.86% 118.41B 8.25% 116.11B 10.29% 115.27B 14.69% 112.01B
Equity
Share capital
0% 3.12B 0% 3.12B 0% 3.12B 0% 3.12B
Reserve
-- -- 10.38% 58.77B -- -- 11.79% 54.67B
Legal reserve
18.23% 1.79B 10.38% 58.77B 18.52% 1.51B 11.79% 54.67B
Capital reserve
-0.34% 20.43B -- -- -0.23% 20.4B -- --
Undistributed profit
16.98% 38.13B -- -- 18.92% 34.93B -- --
Special items of shareholders' rights and interests
43.29% 11.84M 0% -3.84M 37.63% 9.15M 93.49% -3.84M
Shareholders' Equity
9.95% 63.47B 9.81% 61.89B 10.6% 59.96B 11.2% 57.79B
Non-controlling interest
11.97% 38.8B 12.44% 37.77B 13.46% 36.41B 15.14% 35.39B
Total equity
10.71% 102.27B 10.79% 99.65B 11.67% 96.37B 12.66% 93.18B
Total equity and total liabilities
8.96% 360.56B 7.77% 335.41B 8.09% 350.42B 12.4% 344.33B
Currency Unit
CNYCNYCNYCNY
Accounting Standards
CAS (2007)HKASCAS (2007)HKAS
Audit Opinions
--Unqualified Opinion----
Auditor
--Ernst & Young accounting firm (special general partnership), Ernst & Young accounting firm----

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%